Indication: VONVENDI [von Willebrand factor (recombinant)] is used in adults (age 18 years and older) diagnosed with von Willebrand disease to: treat and control bleeding episodes and prevent excessive bleeding during and after surgery


About VONVENDI® [von Willebrand factor (Recombinant)]

See what it means to be a recombinant von Willebrand factor

What is Recombinant?

See what it means to be a recombinant von Willebrand factor

Learn more

Genetically engineered

VWF without the addition of any raw human or animal materials4

Read more about it

How VONVENDI works

Learn how the blood clotting process can be supported

See how it works
Find out about efficacy in the clinical study

VONVENDI efficacy

Find out how bleeding episodes were controlled with VONVENDI in clinical studies

See study results
Free trial program for VONVENDI

VONVENDI free trial program

Eligible patients can try VONVENDI with 3 free doses

Learn more